Clinical Trials
30 trialsIs Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
Tianjin Medical University Second Hospital
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
ASCaP
Jonsson Comprehensive Cancer Center
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
M.D. Anderson Cancer Center
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
DIVINE
Mayo Clinic
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population
Hospital Moinhos de Vento
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
M.D. Anderson Cancer Center
AS
Institute of Cancer Research, United Kingdom
PCASTT
Uppsala University
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
NEO-BLAST
University of British Columbia
TTOPROST/OBS
Fundacion IMIM
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
EASE
Azienda Ospedaliero Universitaria Maggiore della Carita
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
Guy's and St Thomas' NHS Foundation Trust
DETECT I
University College, London
START
Rete Oncologica Piemonte, Valle d'Aosta
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Roswell Park Cancer Institute
DISRUPT
Rigshospitalet, Denmark
PREFERE
Association of Urologic Oncology (AUO)
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Case Comprehensive Cancer Center
PLiS
University College, London
Protocol Active Surveillance Small Renal Masses (SRMs)
IRCCS San Raffaele
Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
IVI Barcelona
SUPER-PC-AS
Seoul National University Hospital
Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Vanderbilt University Medical Center
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
Roswell Park Cancer Institute
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
Roswell Park Cancer Institute